Introduction
Th e anatomy of the anterior commissure (AC) and its impact as a tumor barrier have been the subjects of several investigations and are still subjects of controversy. [1] [2] [3] [4] In addition to the mucosa, the AC includes the intermediate lamina of the thyroid cartilage and the AC tendon (also known as Broyles ligament) with its related structures.
1 Th e AC tendon represents a confl uence of the vocal ligament, the thyroepiglottic ligament, the conus elasticus, and the internal perichondrium of the thyroid ala.
Some authors believe that the AC is a vulnerable location for tumor spread because it is here that the AC tendon inserts into the thyroid cartilage, and its involvement might induce susceptibility to tumor invasion. Th e lack of perichondrium or periosteum in the area of insertion of the AC tendon may allow invasion of tumors into the laryngeal skeleton. [1] [2] [3] [4] [5] Because only a few millimeters separate the AC mucosa from the thyroid cartilage, a small tumor on the AC surface actually may penetrate the cartilage, thus changing the tumor staging. 6 However, some investigators believe that the AC tendon may act as a tumor barrier to glottic cancer, preventing invasion of the adjacent thyroid cartilage by cancer limited to the glottic level (T1a, T1b). 3, 7 Early squamous cell carcinoma of the vocal folds has traditionally been treated with curative radiotherapy ENT-Ear, Nose & Throat Journal ■ May 2011 suspicious lesion. Th e mean follow-up period was 38.4 months (range: 18 to 84 months).
Recurrent or persistent tumors aft er radiotherapy were treated either with open salvage surgery (partial or total laryngectomy) or endoscopic CO 2 laser resection. Surgical specimens were available only from patients treated with open surgical techniques, either as the fi rst line of treatment or as salvage therapy for persistent or recurrent tumors aft er radiotherapy.
During the microscopic evaluation, the greatest attention was given to those slices most representative of the tumor in relation to the thyroid cartilage.
Results
Twenty-two tumors from the patients who underwent open surgery, either initially (n = 8) or as salvage surgery aft er unsuccessful radiotherapy (n = 14), were examined. Microscopic invasion of the thyroid cartilage was detected in 9 of the 22 (40.9%) examined tumors (table). Of the 24 patients treated with radiotherapy, 9 (37.5%) had a complete response and 15 (62.5%) had persistent cancer or developed a local recurrence; 14 of 15 (93.3%) patients in the latter group underwent open surgery, and 1 patient (6.7%) underwent endoscopic CO 2 laser resection.
Microscopic invasion of the thyroid cartilage was detected in only 3 of the 14 (21.4%) examined tumors excised from patients who underwent open surgery aft er irradiation failure. All 3 cases showed indications of moderately diff erentiated squamous cell carcinoma, including basal cell proliferation, intermediate prickle cell hyperplasia with keratohyalin granules, and variable areas of keratin formation. Tumor edges appeared as round masses forming an expanding border; this border is sometimes referred as the tumor's "pushing border, " suggesting that these tumors invade by pressure rather than by cell infi ltration. A layer of multinucleated giant cells at the interface between the tumor and cartilage was noted in 2 cases (fi gure).
with an excellent cure rate (85 to 95%) and preservation of voice quality. 8, 9 However, glottic tumors that involve the AC have been viewed diff erently. Questions about whether AC involvement is an adverse prognostic factor, and whether the cause is anatomic or technical, have been the subjects of much research and still require further investigation.
Anatomically, the AC tendon penetrates the thyroid cartilage and causes dehiscence of the perichondrium at its site of insertion. Th is disruption might induce susceptibility to tumor invasion. 10, 11 Technically, the reduced local control can be attributed to underdosage of radiation to the AC, as postulated by some investigators, owing to the type of energy used. 12, 13 Th e AC is located near the air-tissue interface, and there is a greater risk of underdosage at that interface with the depth-dose characteristics of 4 MV or 6 MV using a linear accelerator than with those of cobalt-60.
Th e aims of the present study were (1) to evaluate the behavior of glottic cancer involving the AC with regard to its tendency to invade the cartilage and (2) to analyze the role of thyroid cartilage invasion by tumor cells at the AC as a possible anatomic cause for recurrent or persistent tumors aft er curative radiotherapy.
Patients and methods
Our study included 36 patients with glottic cancer involving the AC who were treated with curative intent between 1997 and 2007 at the Department of Otolaryngology, Second Hospital, Fujita Health University, School of Medicine, Nagoya, Japan. Th ey represented 37.1% of the 97 patients treated for glottic cancer during the same period. Th e mean age of the patients was 65.25 years (range: 46 to 84 years).
Th irty-four patients were men, and only 2 were women. Th e patients were classifi ed according to the 2002 International Union Against Cancer (UICC) larynx staging system, 14 by means of preoperative clinical records and computed tomography (CT) and endoscopic fi ndings, as follows: 8 T1a (22.2%), 12 T1b (33.3%), 7 T2 (19.4%), and 9 T3 (25%). Of the 36 patients, 24 were treated with radiotherapy as the primary treatment modality, and 12 were treated surgically (8 with open surgery and 4 with endoscopic CO 2 laser resection).
Radiotherapy was administered using the same technique for all patients. A linear accelerator with a beam energy of 4 MV photons was used. A mean dose of 66 Gy (range: 60 to 70 Gy) in 2-Gy fractions was delivered with one fraction per day, 5 days per week. Aft er completion of the radiotherapy regimen, tumor response was evaluated by endoscopic examination and biopsy of any 
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All 3 tumors with thyroid cartilage microinvasion were staged as T2 lesions either before radiotherapy started or aft er showing evidence of recurrence or persistent disease.
Discussion
Th e special anatomic characteristics of the AC make this site even more diffi cult to stage than other parts of the larynx. Tumors originating in this area represent one of the greatest challenges for laryngeal cancer evaluation and treatment because the behavior of tumors in this region seems to be somewhat diff erent from that of other glottic tumors. Th ey deserve special consideration when treatment modalities are considered. Th e absence of internal perichondrium in the thyroid cartilage, in the region of insertion of the AC tendon, may account for the frequency with which tumors are found invading the cartilage at this point. 2, 3 In the present study, microinvasion of the thyroid cartilage was found in 9 of 22 (40.9%) examined tumors. Barbosa et al studied 52 patients with laryngeal cancer (stages T1 to T4) involving the AC and observed thyroid cartilage invasion in 42.3% of the examined tumors. 15 Rifai and Khattab performed a whole-organ section study of 30 excised larynges with AC carcinoma, and they confi rmed the presence of cartilage invasion in all studied specimens. 16 Th e prognostic signifi cance of AC involvement in the local control of glottic cancer treated with radiotherapy has been controversial. Some investigators have failed to fi nd a correlation between AC involvement and an increased local failure rate, 12, 17 whereas others have found a signifi cantly increased local failure rate. 11, 18 In our study, we identifi ed an increased local failure rate in patients with glottic cancer involving the AC and treated with radiotherapy using a 4-MV linear accelerator. We investigated 24 cases of patients with laryngeal cancer involving the AC who had been treated with radiotherapy and found that 15 (62.5%) of them developed local recurrence or had persistent cancer.
Maheshwar and Gaff ney examined 14 patients treated with radiotherapy for T1 glottic cancer involving the AC; 8 (57%) of these patients developed recurrences. 19 Th ese fi ndings were supported by Shvero et al in a study of 64 patients, 20 Nozaki et al in a study of 14 patients, 21 and Jin et al in a study of 70 patients. 22 Th e cause of radiotherapy failure, whether technical or anatomic, represents another subject of controversy among researchers. Chen et al reported that AC involvement is a signifi cant factor for a poor prognosis in T1 glottic cancer treated with linear accelerator radiotherapy devices. 23 Th ey found that 5-year local control rates for patients with and without AC involvement were 55 and 90%, respectively. Interestingly, these eff ects were seen only in patients treated with a linear accelerator unit and not in those treated with a cobalt-60 unit.
Other investigators have reported that AC involvement is a signifi cant prognostic factor for patients treated with both cobalt-60 and linear accelerators and have suggested that the AC, through its specifi c anatomic features, may represent a weak point for tumor spread, regardless of the type of energy used. 11, 24 However, most of the studies concluding that the anatomic features of the AC are the main cause of radiotherapy failure 11, 20, 24 lacked a microscopic examination of the AC region to detect histopathologic evidence supporting this concept, as was performed in our study. Interestingly, we found that microinvasion of the thyroid cartilage in the region of the AC was absent in approximately 79% of patients who underwent open surgery aft er failed radiotherapy. Th ese results may represent pathologic evidence that anatomic risk factors are not the main cause of radiotherapy failure in these patients.
In conclusion, there has been much controversy about whether AC involvement in laryngeal glottic cancer is an adverse prognostic factor and whether the cause of irradiation failure is anatomic or technical. Our study identifi ed an increased local failure rate in patients with glottic cancer involving the AC and treated with radiotherapy. However, we identifi ed pathologic evidence suggesting that anatomic risk factors are not the main cause of radiotherapy failure in these patients, but that technical risk factors should also be considered when discussing this issue. 
